Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma

Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma

Abstract Background Meningiomas are the most common primary tumors of the central nervous system. In patients with WHO grade I meningiomas no adjuvant therapy is recommended after resection. In case of anaplastic meningiomas (WHO grade III), adjuvant fractionated radiotherapy is generally recommende...

Full description

Bibliographic Details
Main Authors: Saman Moritz Hemmati, Pirus Ghadjar, Arne Grün, Harun Badakhshi, Sebastian Zschaeck, Carolin Senger, Güliz Acker, Martin Misch, Volker Budach, David Kaul
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Radiation Oncology
Subjects:
Atypical meningioma
Adjuvant radiotherapy
Fractionated stereotactic radiotherapy
Online Access:http://link.springer.com/article/10.1186/s13014-019-1368-z

Internet

http://link.springer.com/article/10.1186/s13014-019-1368-z

Similar Items